China leads in vaccine race – experts

BEIJING: The battlefield of a global vaccine race has seemingly transferred from research and development to the market after Russia announced its approval of the world’s first coronavirus disease 2019 (Covid-19) vaccine on Tuesday, soon after which the United States announced to purchase another 100 million doses of a domestic candidate, revealing the Trump administration’s anxiety over Russia’s move.

Chinese experts predicted that the move would be a big leap indicating that humans are moving from research and development (R&D) on a Covid-19 vaccine to the market, which would encourage more nations to accelerate their pace while the pandemic has not yet been brought under control globally.